Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the recipient of a significant drop in short interest in November. As of November 30th, there was short interest totalling 800 shares, a drop of 20.0% from the November 15th total of 1,000 shares. Based on an average daily trading volume, of 15,800 shares, the days-to-cover ratio is presently 0.1 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

NASDAQ IBBQ opened at $22.20 on Monday. The stock’s fifty day moving average is $23.31 and its two-hundred day moving average is $23.45. The firm has a market capitalization of $36.19 million, a P/E ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $20.14 and a fifty-two week high of $24.84.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 27th. Investors of record on Monday, September 23rd were issued a $0.089 dividend. The ex-dividend date was Monday, September 23rd. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.60%. This is a positive change from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

A hedge fund recently bought a new stake in Invesco Nasdaq Biotechnology ETF stock. ORG Partners LLC acquired a new position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,067 shares of the company’s stock, valued at approximately $25,000. ORG Partners LLC owned about 0.07% of Invesco Nasdaq Biotechnology ETF as of its most recent filing with the Securities and Exchange Commission.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.